1. Home
  2. MLTX vs ATLC Comparison

MLTX vs ATLC Comparison

Compare MLTX & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$10.87

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Atlanticus Holdings Corporation

ATLC

Atlanticus Holdings Corporation

SELL

Current Price

$94.80

Market Cap

1.7B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
MLTX
ATLC
Founded
2021
1996
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
MLTX
ATLC
Price
$10.87
$94.80
Analyst Decision
Buy
Strong Buy
Analyst Count
15
4
Target Price
$28.54
★ $130.60
AVG Volume (30 Days)
★ 1.8M
81.8K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 24.95
EPS
N/A
★ 4.74
Revenue
N/A
★ $1,968,399,000.00
Revenue This Year
N/A
$441.71
Revenue Next Year
N/A
$13.74
P/E Ratio
★ N/A
$19.73
Revenue Growth
N/A
★ 50.09
52 Week Low
$8.80
$47.50
52 Week High
$23.29
$114.34

Technical Indicators

Market Signals
Indicator
MLTX
ATLC
Relative Strength Index (RSI) 26.48 55.00
Support Level N/A $91.00
Resistance Level $19.24 $97.87
Average True Range (ATR) 0.61 3.07
MACD -0.00 0.53
Stochastic Oscillator 5.37 88.23

Price Performance

Historical Comparison
MLTX
ATLC

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

Share on Social Networks: